NovaBay Pharmaceuticals Inc (NBY)
0.0757
0.00 (0.00%)
USD |
NYAM |
Apr 25, 10:02
NovaBay Pharmaceuticals Price to Book Value: 1.670 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 1.706 |
| April 23, 2024 | 1.699 |
| April 22, 2024 | 1.600 |
| April 19, 2024 | 1.818 |
| April 18, 2024 | 1.854 |
| April 17, 2024 | 1.829 |
| April 16, 2024 | 1.754 |
| April 15, 2024 | 1.798 |
| April 12, 2024 | 1.995 |
| April 11, 2024 | 1.977 |
| April 10, 2024 | 2.019 |
| April 09, 2024 | 1.918 |
| April 08, 2024 | 2.032 |
| April 05, 2024 | 2.231 |
| April 04, 2024 | 2.308 |
| April 03, 2024 | 2.302 |
| April 02, 2024 | 2.299 |
| April 01, 2024 | 2.315 |
| March 28, 2024 | 2.310 |
| March 27, 2024 | 2.454 |
| March 26, 2024 | 3.067 |
| March 25, 2024 | 2.844 |
| March 22, 2024 | 3.005 |
| March 21, 2024 | 3.028 |
| March 20, 2024 | 3.089 |
| Date | Value |
|---|---|
| March 19, 2024 | 3.045 |
| March 18, 2024 | 3.089 |
| March 15, 2024 | 3.089 |
| March 14, 2024 | 2.972 |
| March 13, 2024 | 3.125 |
| March 12, 2024 | 3.030 |
| March 11, 2024 | 1.155 |
| March 08, 2024 | 1.158 |
| March 07, 2024 | 1.171 |
| March 06, 2024 | 1.194 |
| March 05, 2024 | 1.218 |
| March 04, 2024 | 1.236 |
| March 01, 2024 | 1.256 |
| February 29, 2024 | 1.203 |
| February 28, 2024 | 1.269 |
| February 27, 2024 | 1.172 |
| February 26, 2024 | 1.229 |
| February 23, 2024 | 1.268 |
| February 22, 2024 | 1.260 |
| February 21, 2024 | 1.222 |
| February 20, 2024 | 1.301 |
| February 16, 2024 | 1.364 |
| February 15, 2024 | 1.309 |
| February 14, 2024 | 1.246 |
| February 13, 2024 | 1.129 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1789
Minimum
Dec 27 2022
60.30
Maximum
Aug 04 2020
5.768
Average
1.995
Median
Apr 12 2024
Price to Book Value Benchmarks
| Eyenovia Inc | 2.980 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7084 |
| Theriva Biologics Inc | 0.1690 |
| Oragenics Inc | 3.100 |
Price to Book Value Related Metrics
| PS Ratio | 0.0271 |
| Price | 0.0757 |
| Earnings Yield | -4.37K% |
| Market Cap | 2.278M |